Patents
Patents for C07J 15 - Stereochemically pure steroids containing carbon, hydrogen, halogen, or oxygen, having a partially or totally inverted skeleton, e.g. retrosteroids, l-isomers (136)
09/2014
09/18/2014WO2014144945A2 Power assisted bow
09/18/2014US20140275572 Synthesis of ent-progesterone and intermediates thereof
02/2010
02/11/2010WO2010015875A1 Process for the preparation of lanosta-8-ene compou
11/2008
11/20/2008WO2008113851A3 Novel c11 modified retrosteroids as progesterone receptor modulator compounds
09/2008
09/03/2008CN101258159A Novel c18 modified retrosteroids as progesterone receptor modulator compounds
08/2008
08/13/2008CN101239090A Pharmaceutical compositions having appetite suppressant activity
08/13/2008CN101239089A Pharmaceutical compositions having appetite suppressant activity
06/2008
06/11/2008EP1928894A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds
04/2008
04/02/2008CN100378118C Pharmaceutical compositions having appetite suppressant activity
07/2007
07/10/2007CA2283564C Pharmaceutical compositions having appetite suppressant activity
04/2007
04/12/2007WO2007039544A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds
04/12/2007CA2624015A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds
01/2007
01/23/2007US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
11/2006
11/02/2006EP0973534B1 Plant extracts having appetite suppressant activity
09/2006
09/14/2006US20060205931 Pharmaceutical compositions having appetite suppressant activity
08/2006
08/23/2006CN1821261A Steroid C,D cycle rearrangement formed compounds
02/2006
02/01/2006EP1169336B1 Ent-steroids as selectively active estrogens
01/2006
01/24/2006CA2151561C Hydrazino and hydroxyamino-14.beta.-hydroxyandrostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
12/2005
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
11/2005
11/23/2005EP1598054A2 Method of suppressing appetite
09/2005
09/28/2005EP1580192A2 16-Hydroxyestratrienes as selective estrogens
04/2005
04/19/2005US6881728 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
11/2004
11/25/2004US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/18/2004US20040228935 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction
07/2004
07/21/2004EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite
05/2004
05/04/2004CA2090264C Method of preparing 9beta, 10alpha-5,7-diene steroids
08/2003
08/28/2003WO2002040032A3 Cytoprotective estrogen derivatives
05/2003
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
11/2002
11/20/2002EP1163259B1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens
11/14/2002US20020168427 Plant extract
09/2002
09/19/2002US20020132802 Cytoprotective polycyclic compounds
08/2002
08/20/2002US6437157 (20s)(8a,9b,13a,14b,17a) 20-(((dimethylamino)-ethyl)-amino) -19-nor-delta.sup.1,3,5(10)-pregnatrien-3-ol; acylation or alkylation of an estrone, cyanation, oximation; fertility control in males
07/2002
07/17/2002EP1222927A2 Pharmaceutical compositions having appetite suppressant activity
06/2002
06/12/2002EP1213020A2 Pharmaceutical compositions having appetite suppressant activity
05/2002
05/23/2002WO2002040032A2 Cytoprotective estrogen derivatives
05/22/2002CN1350543A 14 beta-H-sterols, PHarmaceutical composiutions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
04/2002
04/24/2002CN1346364A 16-hydroxyestratrienes as selective estrogens
04/23/2002US6376657 Pharmaceutical compositions having appetite suppressant activity
02/2002
02/06/2002EP1177205A1 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS
01/2002
01/09/2002EP1169336A1 Ent-steroids as selectively active estrogens
12/2001
12/19/2001EP1163259A1 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens
10/2001
10/17/2001EP1144431A2 16-hydroxyestratrienes as selective estrogens
09/2001
09/07/2001WO2000047603A9 16-hydroxyestratrienes as selective estrogens
08/2001
08/02/2001WO2000047603A3 16-hydroxyestratrienes as selective estrogens
08/02/2001EP1144431A3 16-hydroxyestratrienes as selective estrogens
01/2001
01/23/2001US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid
11/2000
11/16/2000WO2000068245A1 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS
11/16/2000CA2373442A1 14.beta.-h-sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
10/2000
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/19/2000DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
09/2000
09/14/2000WO2000053619A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
09/14/2000CA2359218A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
08/2000
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
05/2000
05/24/2000CN1052729C Steroids containing in position 20 aminosubstituted chain, their preparation process and use, and pharmaceutical compositions containing them
05/03/2000CN1252000A Pharmaceutical compositions having appetite suppressant activity
01/2000
01/26/2000EP0973534A1 Pharmaceutical compositions having appetite suppressant activity
03/1999
03/03/1999EP0754190B1 An equilin double bond isomer from the acid isomerization of equilin
02/1999
02/25/1999WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity
12/1998
12/09/1998EP0882735A1 9 Alpha-hydroxy-8 alpha-estra-1,3,5(10)-trienes and a process for their preparation
10/1998
10/22/1998WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
09/1998
09/16/1998EP0863914A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents
06/1998
06/10/1998DE19723390C1 New 9-alpha-hydroxy-8-alpha-oestratriene derivatives
10/1997
10/21/1997US5679668 Method of controlling fertility in males with 20-substitute of steroids
06/1997
06/24/1997US5641767 Modified bile acids process for their preparation and their use
05/1997
05/07/1997CN1149298A An equilin double bond isomer from the acid isomerization of equilin
03/1997
03/20/1997WO1997010256A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents
03/20/1997DE19535851A1 New 18-nor-steroid cpds.
02/1997
02/04/1997US5599806 Hydrazino and hydroxyamino-14-β-hydroxyandrostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
01/1997
01/22/1997EP0754190A1 An equilin double bond isomer from the acid isomerization of equilin
01/21/1997US5596110 Process for the preparation of 3 β, 14 β-dihydroxyethianaldehyde
01/08/1997CN1033753C Process for the preparation of 11 beta-phenyl-gonanes
10/1996
10/31/1996DE19516325A1 High yield prodn. of new or known 14(15)-unsatd. 17alpha-substd. steroid cpds.
09/1996
09/03/1996US5552395 Bone disorders
04/1996
04/09/1996US5506221 Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents
03/1996
03/20/1996EP0702026A2 Modified bile acids, a process for their production and their use
03/13/1996CN1118352A New steroids containing in position 20 an aminosubstitued chain, preparation procass and intermediates of this process, use as medicaments and pharmaceutical compositions containing them
03/05/1996US5496814 Steroids for bone disorders and oxidation resistance
12/1995
12/27/1995EP0688786A1 New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same
11/1995
11/29/1995EP0684256A2 Improved process for the preparation of 3 beta, 14 beta-dihydroxyethialnaldehyde
10/1995
10/19/1995WO1995027724A1 An equilin double bond isomer from the acid isomerization of equilin
10/19/1995CA2186486A1 An equilin double bond isomer from the acid isomerization of equilin
10/04/1995EP0675134A1 New 20-amino substituted steroid compounds, a method for their production and intermediates therefor and pharmaceutical compositions containing them
10/02/1995CA2146085A1 Steroids containing an aminosubstituted chain in position 20; process and intermediates therefor; their use as drugs and pharmaceutical compositions containing them
09/1995
09/27/1995EP0673251A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
09/06/1995EP0669932A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
09/06/1995EP0669931A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase
08/1995
08/29/1995US5446036 13-alkyl-11beta-phenylgonanes
04/1995
04/26/1995CN1101916A Compounds
04/26/1995CN1101914A Compounds
03/1995
03/07/1995US5395831 Atherosclerosis and osteoporosis treatment
03/07/1995CA1334668C 13-alkyl-11beta-phenylgonanes
05/1994
05/26/1994WO1994011386A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
05/26/1994WO1994011385A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase
05/26/1994WO1994011004A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
05/26/1994CA2149427A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
04/1994
04/19/1994US5304291 Method of preparing 9beta, 10alpha-5,7-diene steroids
1 2